LncRNA Information | |||||
---|---|---|---|---|---|
ID | EL0483 | Name | BACE1 | Aliases | ASP2, BACE, HSPC104 |
Species | Homo sapiens | Chromosome | 11 | Start site | 117285207 |
End site | 117316256 | Chain | minus | Exon NO. | 10 |
Assembly | GRCh38.p13 | Class | lncRNA | NCBI accession | N/A |
Ensembl | N/A | Sequence | N/A | Peptide-related | N/A |
CircRNA | yes | Exosomal | N/A | Structure | N/A |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Drug/chemo/stress | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | ||
alzheimer's disease | qRT-PCR | 88聽AD patients and 72 control individuals | up-regulated | expression | Our present study compared the plasma level of four LncRNA between AD and non-AD patients, and found that the level of the BACE1 is increased in the plasma of AD patients and have a high specificity (88%) for AD, indicating BACE1 may be a potential candidate biomarker to predict AD. | 29316899 |